Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin; Faith B. Davis; Paul  J. Davis; Shaker A. Mousa

Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin (发明人), Faith B. Davis (发明人), Paul J. Davis (发明人), Shaker A. Mousa (发明人)

臺北醫學大學癌症轉譯研究中心

研究成果: 專利

摘要

Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

原文	英語
出版狀態	已發佈 - 2010

UN SDG

此研究成果有助於以下永續發展目標

存取文件

https://patents.google.com/patent/US9180107B2/en

引用此

@misc{40c88d1231914ee2b4b8c54bc016f246,

title = "Combination treatment of cancer with cetuximab and tetrac",

abstract = "Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.",

author = "Hung-Yun Lin and {B. Davis}, Faith and {J. Davis}, Paul and {A. Mousa}, Shaker",

year = "2010",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Combination treatment of cancer with cetuximab and tetrac

AU - Lin, Hung-Yun

AU - B. Davis, Faith

AU - J. Davis, Paul

AU - A. Mousa, Shaker

PY - 2010

Y1 - 2010

N2 - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

AB - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

M3 - Patent

ER -

Combination treatment of cancer with cetuximab and tetrac

摘要

UN SDG

存取文件

指紋

引用此